docs: correct Shield positioning — standalone compliance, not DMEPOS-specific
This commit is contained in:
parent
e0590a0397
commit
96cbedbf77
1 changed files with 1 additions and 1 deletions
|
|
@ -19,7 +19,7 @@ implying Signal contacts prescribers or patients directly.
|
|||
|
||||
- LabABLE Meeting Fri 2026-06-26 1:30 PM — /pilot-prep (deferred).
|
||||
- Build Spec Phase 2 + Phase 4: Claude Code to build. Pi verifies after.
|
||||
- Shield competitor: Dash ComplyOps ($250/mo, horizontal compliance). Shield differentiator = DMEPOS vertical expertise. Insight planted in TriLane.
|
||||
- Shield competitor: Dash ComplyOps ($250/mo, horizontal compliance). Shield is standalone compliance product (not DMEPOS-specific). Differentiator: simplicity + optional Signal bundling for DMEPOS suppliers. Insight corrected in TriLane.
|
||||
- 3 validation product blockers: MA misclassification, duplicate patient_id, doc-status override (Claude Code on these).
|
||||
- Primary domain sttilsolutions.com still "Pending" in Clerk (non-blocking for auth).
|
||||
- Primary domain sttilsolutions.com still "Pending" in Clerk (non-blocking for auth).
|
||||
|
|
|
|||
Loading…
Reference in a new issue